Prediction Tools: Disclaimer
The prediction tools, also known as prognostic nomograms, located on the MSKCC Web site are for general health information only. The prediction tools are not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem.
Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other healthcare provider.
MSKCC makes no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in the prediction tools. MSKCC does not assume any risk whatsoever for your use of the prediction tools or the information contained herein. Health related information changes frequently and therefore information contained in the prediction tools may be outdated, incomplete or incorrect.
Use of the prediction tools does not create an express or implied physician-patient relationship. MSKCC does not endorse or claim validity for the prediction tools found on the MSKCC Web site. The activities and products of MSKCC and its developers and agents (collectively MSKCC) are not endorsed by our past, present, or future employers. MSKCC does not record specific prediction tool user information and does not contact users of the prediction tools.
You are hereby advised to consult with a physician or other professional healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future. In using the prediction tools, you agree that neither MSKCC nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented in the prediction tools.
Our melanoma sentinel lymph node metastasis nomogram is a tool designed to predict the probability that a patient’s skin melanoma has metastasized (spread) to the sentinel lymph node (the first lymph node to which cancer cells are likely to spread from the primary tumor). This tool can be used by patients with skin melanoma who have had their melanoma biopsied or surgically removed, but it is not appropriate for patients with melanoma who have already had a sentinel lymph node biopsy or who have enlarged lymph nodes in proximity to the melanoma on physical examination.
Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of melanoma procedures. This tool was externally validated using data from a large, multi-institutional clinical trial, and was further evaluated and validated by three separate institutions (see
Supporting Publications). All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
To gather the information required to use this nomogram, use our worksheet.